# Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

> **NCT02684409** · PHASE1 · COMPLETED · sponsor: **NuPathe Inc.** · enrollment: 37 (actual)

## Conditions studied

- Acute Migraine

## Interventions

- **DRUG:** PROT-CL-NP101-015.01

## Key facts

- **NCT ID:** NCT02684409
- **Lead sponsor:** NuPathe Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684409, "Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02684409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*